Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Application of magnolol to preparation of medicine for treating cachexia and cancer

A technology of magnolol and cachexia, applied in the field of application of magnolol in the preparation of drugs for treating cachexia and cancer

Active Publication Date: 2014-02-19
赖媛淑
View PDF2 Cites 5 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, there is no prior art revealing that magnolol can be used to treat cachexia

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of magnolol to preparation of medicine for treating cachexia and cancer
  • Application of magnolol to preparation of medicine for treating cachexia and cancer
  • Application of magnolol to preparation of medicine for treating cachexia and cancer

Examples

Experimental program
Comparison scheme
Effect test

example

[0053] 1. Materials and methods

[0054] 1.1 Magnolol (magnolol)

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses applications of magnolol, or isomers of magnolol or salts of compounds that are acceptable in pharmaceutical areas to preparation of medicines for treating cachexia and cancers. The cachexia may be caused by selection of the following groups of diseases, states or damage: cancers, immunodeficiency diseases, infectious diseases, autoimmune diseases, metabolic diseases, chronic bowel, liver, kidney, lung and heart diseases, anorexia nervosa, trauma, burning, malabsorption and anemia. In one embodiment, the medicines can be taken by patients that may suffer from cachexia such as cancers. The invention also provides applications of magnolol, or isomers of magnolol or salts of compounds that are acceptable in pharmaceutical areas to preparation of medicines for treating bladder cancers, especially applications to prevention of tumor growth and cancel cell metastasis of bladder cancers and to improvements of animal survival rates.

Description

[0001] Cross References to Related Applications [0002] This application claims priority to Taiwan Provisional Patent Application No. 101129398 filed on August 14, 2012, the specification of which is incorporated herein by reference in its entirety. technical field [0003] The invention relates to the application of magnolol or its isomers or pharmaceutically acceptable salts of these compounds in the preparation of drugs for treating cachexia and cancer. The medicament of the present invention can be administered to individuals in need, such as cachexia patients, to improve or alleviate the symptoms of cachexia. The invention also relates to the application of magnolol in the preparation of medicines for treating bladder cancer, especially for inhibiting bladder cancer tumor growth or cancer cell metastasis. Background technique [0004] Cachexia (cachexia) is a complex metabolic syndrome produced under disease conditions. The main clinical symptoms are muscle wasting an...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K31/05A61K45/00A61P35/00A61P21/00A61P29/00A61P1/14
Inventor 赖媛淑
Owner 赖媛淑
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products